Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Product Outlook: Segment | Synthetic Fabric Graft, Stent-graft |
| Age-Group Outlook: Segment | Adult, Geriatric, Pediatric |
| Material Outlook: Segment | Polymer, Metal |
|---|---|
| Aortic Length Outlook: Segment | Above 50 mm, Above 100 mm |
| End-user Outlook: Segment | Hospitals, Ambulatory Surgical Centers, Research Institutes |
| Regions & Countries |
|
Rising prevalence of risk factors Growth in adoption of unhealthy lifestyle Increasing awareness and screening initiatives
High costs associated with endovascular procedures and devices Issues with Concerns About Long-Term Sturdiness
Transition to off-the-shelf and custom fenestrated and branching endografts Advancements in endovascular technology
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The Endovascular abdominal aortic aneurysm repair devices Market is highly competitive, characterized by the presence of several global and regional players offering a wide range of products. Key companies in the market, such as Lombard Medical Inc., Koninklijke Philips N.V., Terumo Medical Corporation, and W. L. Gore & Associates, Inc., dominate through their extensive product portfolios, strong distribution networks, and focus on innovation.
In June 2022, Cardiva Medical, Inc. and Medtronic plc announced a distribution deal for the latter's sutureless aortic valve, the Aorfix device. Through these collaborations, businesses can access new markets and technological advancements and capitalize on complementary strengths. (Source: https://news.medtronic.com/Medtronic-receives-CE-Mark-for-Evolut-TM-FX-TAVI-system-for-treatment-of-symptomatic-severe-aortic-stenosis) In October 2022, Terumo Aortic introduced the RelayPro proximal stent graft system, which is intended to give complex aortic anatomy a conformable and personalized fit. (Source: https://terumoaortic.com/products/relaypro/)
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Medtronic | ••• | ••• | ••• | ••• |
| Cook | ••• | ••• | ••• | ••• |
| Abbott Laboratories | ••• | ••• | ••• | ••• |
| Becton | ••• | ••• | ••• | ••• |
| Dickinson and Company | ••• | ••• | ••• | ••• |
| Cardinal Health Inc. | ••• | ••• | ••• | ••• |
| Endologix Inc. | ••• | ••• | ••• | ••• |
| Lombard Medical Inc. | ••• | ••• | ••• | ••• |
| Koninklijke Philips N.V. | ••• | ••• | ••• | ••• |
| Terumo Medical Corporation | ••• | ••• | ••• | ••• |
| W. L. Gore & Associates Inc. | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →According to Cognitive Market Research, the global Endovascular abdominal aortic aneurysm repair devices Market size will be USD 2561.5 million in 2025. It will expand at a compound annual growth rate (CAGR) of 5.50% from 2025 to 2033.
Endovascular abdominal aortic aneurysm (AAA) repair devices are minimally invasive medical devices used to treat AAA, or the bulging of the abdominal aorta. The plan is to inject these devices via a tiny groin incision and then guide them to the aneurysm site, where they will be inflated to reinforce the weak vascular walls. There are various types of endovascular AAA repair devices, such as stent-graft and aortic endograft. These devices have been shown to be effective in lowering the risk of aneurysm rupture and improving patient outcomes, which is positively affecting the market value of endovascular abdominal aortic aneurysm repair devices worldwide. The market is driven primarily by the aging of the population and the increasing prevalence of abdominal aortic aneurysm.
In July 2021, Endologix, Inc., a pioneer in the treatment of vascular disease, revealed that the U.S. Food and Drug Administration has designated the company's ChEVAS (Chimney EndoVascular Aneurysm Sealing) system as a breakthrough device. The ChEVAS system is an endovascular abdominal aortic aneurysm (AAA) sealing technique that combines the Nellix 3.5 endograft with parallel visceral stents to treat patients with pararenal, suprarenal, and juxtarenal abdominal aortic aneurysm. (Source: https://endologix.com/news/endologix-receives-ide-approval-nellix-chimney-endovascular-aneurysm-sealing-protocol/)
Conclusion
★ Reviews
Rate this report
| Product Outlook: | Synthetic Fabric Graft, Stent-graft |
| Age-Group Outlook: | Adult, Geriatric, Pediatric |
| Material Outlook: | Polymer, Metal |
| Aortic Length Outlook: | Above 50 mm, Above 100 mm |
| End-user Outlook: | Hospitals, Ambulatory Surgical Centers, Research Institutes |
| List of Competitors | Medtronic, Cook, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health Inc., Endologix Inc., Lombard Medical Inc., Koninklijke Philips N.V., Terumo Medical Corporation, W. L. Gore & Associates Inc. |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global endovascular abdominal aortic aneurysm repair devices market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.